3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Carcinoma, Basal Cell
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Psoriasis
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Interventions
venetoclax
5
Rituximab
5
Cyclophosphamide
5
zanubrutinib
3
Whole-Body Irradiation
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Cyclosporine
3
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Vincristine
2
Specimen Handling
2
Mycophenolic Acid
2
Doxorubicin
2
Biopsy
2
treosulfan
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.